用外部对照丰富单臂临床试验:可能性与陷阱
文章讨论在缺乏随机对照试验时,用单臂试验结合外部对照进行间接比较的方法。以西达基奥仑赛治疗复发或难治性多发性骨髓瘤为例,提出三步法:定义估计目标、选择外部对照、选择统计方法。作者强调间接比较的治疗效应有效性高度依赖方法学考量,因无法保证随机对照试验的证据水平,评估比标准情形更重要。
要点
- 单臂试验加外部对照可用于间接比较,但治疗效应有效性高度依赖方法学考量。
- 作者提出三步法:定义估计目标、选择外部对照、选择统计方法。
- 因无法保证随机对照试验的证据水平,此类评估比标准情形更重要。
核心结论
- 间接比较所得治疗效应的有效性高度依赖所提出的三步流程中的方法学考量。
- 因无法保证设计良好的随机对照试验的证据水平,此类评估比标准情形更重要。
研究设计与样本
- 本文为方法学指南类文章,旨在为单臂试验外部对照比较的批判性评估或实施提供综合工具。
- 以西达基奥仑赛治疗既往接受3线及以上治疗的复发或难治性多发性骨髓瘤成人患者为示例。
主要发现
- 作者提出三步法:第一步定义估计目标,涵盖治疗效应和目标人群(全人群或限定于单臂试验或外部对照)。
- 第二步依赖从既往随机对照试验或真实世界数据(患者队列、登记数据库或电子病历)中充分选择外部对照。
- 第三步为选择针对上述治疗效应的统计方法,取决于可用数据(个体水平数据或聚合外部数据)。
关键数值与推荐
- 第一步定义估计目标,反映临床问题,涵盖治疗效应和目标人群(全人群或限定于单臂试验或外部对照)。
- 第二步从既往随机对照试验或真实世界数据(患者队列、登记数据库或电子病历)中选择外部对照。
- 第三步选择统计方法,取决于可用数据为个体水平数据或聚合外部数据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 因无法保证设计良好的随机对照试验的证据水平,此类评估比标准情形更重要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For the past decade, it has become commonplace to provide rapid answers and early patient access to innovative treatments in the absence of randomized clinical trials (RCT), with benefits estimated from single-arm trials. This trend is important in oncology, notably when assessing new targeted therapies. Some of those uncontrolled trials further include an external/synthetic control group as an innovative way to provide an indirect comparison with a pertinent control group. We aimed to provide some guidelines as a comprehensive tool for (1) the critical appraisal of those comparisons or (2) for performing a single-arm trial. We used the example of ciltacabtagene autoleucel for the treatment of adult patients with relapsed or refractory multiple myeloma after 3 or more treatment lines as an illustrative example. We propose a 3-step guidance. The first step includes the definition of an estimand, which encompasses the treatment effect and the targeted population (whole population or restricted to single-arm trial or external controls), reflecting a clinical question. The second step relies on the adequate selection of external controls from previous RCTs or real-world data from patient cohorts, registries, or electronic patient files. The third step consists of choosing the statistical approach targeting the treatment effect defined above and depends on the available data (individual-level data or aggregated external data). The validity of the treatment effect derived from indirect comparisons heavily depends on careful methodological considerations included in the proposed 3-step procedure. Because the level of evidence of a well-conducted RCT cannot be guaranteed, the evaluation is more important than in standard settings.
引用
- Lambert J, Lengliné E, Porcher R, et al. Enriching single-arm clinical trials with external controls: possibilities and pitfalls. Blood Adv. 2023. PMID: 36534147. doi:10.1182/bloodadvances.2022009167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。